Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Median Technologies

< Previous 1 2 Next >
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
From Median Technologies
Via Business Wire
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
From Median Technologies
Via Business Wire
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
From Median Technologies
Via Business Wire
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
From Median Technologies
Via Business Wire
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
From Median Technologies
Via Business Wire
New Date for Median Technologies’ Webcasts: February 1st, 2024
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024
From Median Technologies
Via Business Wire
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
From Median Technologies
Via Business Wire
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
From Median Technologies
Via Business Wire
Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations
From Median Technologies
Via Business Wire
Median Technologies Selected for Support Under the French Government's ETIncelles Program
From Median Technologies
Via Business Wire
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
From Median Technologies
Via Business Wire
Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA
From Median Technologies
Via Business Wire
Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023
From Median Technologies
Via Business Wire
First Results of Median Technologies’ iBiopsy® HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain)
From Median Technologies
Via Business Wire
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain
From Median Technologies
Via Business Wire
Median Technologies Appoints Ben McDonald to its Board of Directors
From Median Technologies
Via Business Wire
Median Technologies: Financial Communication Schedule for the Second Half of 2023
From Median Technologies
Via Business Wire
Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023
From Median Technologies
Via Business Wire
Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD
From Median Technologies
Via Business Wire
Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan
From Median Technologies
Via Business Wire
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023
From Median Technologies
Via Business Wire
Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023
From Median Technologies
Via Business Wire
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023
From Median Technologies
Via Business Wire
Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria
From Median Technologies
Via Business Wire
Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
From Median Technologies
Via Business Wire
Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
From Median Technologies
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.